You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA249
  • Published:  15 March 2012
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • History
Download guidance (PDF)
  • Overview
  • 1 Recommendations
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Appraisal Committee members and NICE project team
  • 7 Sources of evidence considered by the Committee
  • Update information

Update information

July 2021: Recommendation 1.2 was updated to include the other anticoagulants approved by NICE.

ISBN: 978-1-4731-4188-9


Previous page 7 Sources of evidence considered by the Committee